Mercy BioAnalytics
PrivateLast Round
Series B
Sep 3, 2025
Total Funding Raised
$127.3M
Momentum Score
25 /100
Company Overview
Mercy BioAnalytics is a biotechnology company that offers a cutting-edge liquid biopsy assay platform for the early detection of cancer through the analysis of tumor-derived extracellular vesicles found in blood.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Healthcare Analytics, Precision Medicine
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mercy BioAnalytics Comps
Public and private peers based on sector, stage, and business model.
Mercy BioAnalytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 3, 2025 | ||||
| Series A | Apr 3, 2023 | ||||
| Series A | Jan 29, 2021 |
Key People
Founding team and executive leadership
Mercy BioAnalytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Horizons | Series A |
| Mindshift Capital | Series B |
| iSelect Fund | Series A, Series B |
| BrightEdge | Series A |
| Portfolia | Series B |
| Hatteras Venture Partners | Series A |
| Avestria Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2026
Darrin Crisitello appointed as new Chief Commercial Officer.
- Dec 16, 2025
Now described as a commercial-stage biotechnology company.
Mercy BioAnalytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mercy BioAnalytics's valuation, stock price, and market status.
